From Foundation to Future: AI-Mind Strengthens Clinical Implementation
From Foundation to Future: AI-Mind Strengthens Clinical Implementation The updated consortium structure, implemented in January 2024, reflects AI-Mind’s evolving priorities (read recent news). New partners, namely the University of Oslo […]
AI-Mind project supplement published with new Dementia in Europe magazine
AI-Mind project supplement published with new Dementia in Europe magazine A special supplement dedicated to the AI-Mind project has been published today alongside the 48th edition of Dementia in Europe […]
A strategic reorientation in the consortium structure
A strategic reorientation in the consortium structure On 22 May 2025, the AI-Mind consortium, joined by the Project Officer and external experts, convened for a pivotal review meeting to assess […]
Innovation, Collaboration, and Open Science: Highlights from AI-Mind’s 10th General Assembly
Innovation, Collaboration, and Open Science: Highlights from AI-Mind’s 10th General Assembly The AI-Mind consortium concluded its 10th General Assembly in the scenic city of Bodø, Norway, bringing together a multidisciplinary […]
AI-Mind 10th General Assembly: Spotlight on Dissemination and Exploitation Strategies
AI-Mind 10th General Assembly: Spotlight on Dissemination and Exploitation Strategies Bodø, Norway | 5–7 May 2025 The AI-Mind consortium is set to convene for its 10th General Assembly, hosted by […]
European Commission approves lecanemab for treatment of early Alzheimer’s disease
European Commission approves lecanemab for treatment of early Alzheimer’s disease In a landmark decision, the European Commission has granted EU-wide authorisation for lecanemab, the first medicine to treat mild cognitive […]
AI-Mind Partners Present at Prestigious Alzheimer’s and Parkinson’s Conference in Vienna
AI-Mind Partners Present at Prestigious Alzheimer’s and Parkinson’s Conference in Vienna Partners from the AI-Mind project are proud to present new research findings this week at the International Conference on […]
AI-Mind Share: A Knowledge Hub for Raising Awareness and Sharing Dementia Research
AI-Mind Share: A Knowledge Hub for Raising Awareness and Sharing Dementia Research To mark Brain Awareness Week 2025, a global campaign to increase public awareness of the progress and benefits […]
Special Supplement on the 34th Alzheimer Europe Conference Now Available
Special Supplement on the 34th Alzheimer Europe Conference Now Available: AI-Mind’s Key Contributions and Insights The 34th Alzheimer Europe Conference (34AEC) took place from 8 to 10 October 2024 in […]
AI-Mind featured at LETHE webinar on AI in dementia research
AI-Mind featured at LETHE webinar on artificial intelligence in dementia research On January 17, AI-Mind was showcased during the third event of the LETHE webinar series, titled “Beyond the hype: […]
New publication from AI-Mind on Framework for Evaluating AI-Based Health Technologies
New publication from AI-Mind on Framework for Evaluating AI-Based Health Technologies The AI-Mind project is excited to announce the publication of “Health Technology Assessment Framework for Artificial Intelligence-Based Technologies” by […]
Positive EMA decision on lecanemab highlights importance of AI-Mind’s work
Positive European Medicines Agency decision on lecanemab highlights importance of AI-Mind’s work On 14 November 2024, the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) recommended […]
Reporting from the AI-Mind 9th General Assembly
The AI-Mind 9th General Assembly Gathers Experts in Madrid On October 28-29, 2023, AI-Mind partners from The Complutense University of Madrid (UCM) hosted the 9th General Assembly in Madrid, Spain, welcoming […]
AI-Mind Featured on Brain Talks Podcast
Pictures by Brain Innovation Days AI-Mind Featured on Brain Talks Podcast On 28 October 2024, the European Brain Council (EBC) released a new episode of Brain Talks, the podcast produced […]
AI-Mind presents results at Alzheimer Europe conference in Geneva
AI-Mind presents results at Alzheimer Europe conference in Geneva The 34th Alzheimer Europe Conference (#34AEC) took place from 8-10 October in Geneva (Switzerland) bringing together over 950 delegates from 42 […]
AI-Mind consortium meets for 9th General Assembly
The AI-Mind consortium meets for 9th General Assembly The AI-Mind consortium will host its 9th General Assembly (GA9) at the Universidad Complutense de Madrid (UCM) from October 28-29, 2024. The […]
AI-Mind joins Strategic Workshop on Multimodal Health Data Integration
AI-Mind Joined Strategic Workshop on Multimodal Health Data Integration On 24 September, AI-Mind participated in a Strategic Workshop on the challenges of multimodal health data integration, alongside fellow EU-funded projects […]
AI-Mind Consortium to present Results at Alzheimer Europe
AI-MIND Consortium to present results at Alzheimer europe The AI-Mind Consortium is set to make a significant contribution to this year’s Alzheimer Europe Conference taking place in Geneva, Switzerland from […]
World Alzheimer’s Month: Spotlight on Mild Cognitive Impairment and the Role of AI-Mind
World Alzheimer’s Month: Spotlight on Mild Cognitive Impairment and the Role of AI-Mind September is World Alzheimer’s Month, a global campaign raising awareness about dementia and related cognitive disorders. This […]
Negative Opinion on Lecanemab for Early Alzheimer’s Disease
Negative Opinion on Eisai’s Lecanemab for Early Alzheimer’s Disease An application for the marketing authorization of lecanemab, a promising treatment for early-stage Alzheimer’s disease, has faced a setback. The European […]